SMYD3 and Alzheimer disease: Viral-based knockdown of Fbxo2 in PFC restores NMDAR-EPSC, leading to the amelioration of cognitive deficits, further confirming the important role of Smyd3-Fbxo2-NR1 pathway in AD pathophysiology.